ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

ACS Board To Consider Proposal For Implementing Cancer Response System Nationwide; Could End CIS

June 7, 1985

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992

Season’s Greetings from the Cancer Letter

December 17, 1999

In Congress: HHS Funding Bill Vetoed, Congress, White House Negotiating on Budget

November 12, 1999

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007